The API product list of Lonzeal covers one major first-line and three second-line ARV drugs, including Lamivudine, Emtricitabine, Lopinavir and Ritonavir. The annual production capacity is 100MT of Lamivudine, 20MT of Emtricitabine, 12MT of Ritonavir and 12MT of Lopinavir. We also focus on R&D of new APIs and keep expanding the anti-HIV product line. The manufacturing site of Lonzeal Pharmaceuticals has total employee of 200 people and land area of 100,000 square meters, consisting of buildings for specific functions, including production workshops, class D clean area, power shop, warehouses, analytical labs and research labs.